Domain | Indicated (%) | Performed (%) | Adherence to the algorithm (%) (PO/TTPx100) | |||
---|---|---|---|---|---|---|
Global | Group N | Group P | p3 | |||
Heat loss prevention | 100 (50/50) | 100 (50/50) | 62 (31/50) | 66.7 (12/18) | 59.4 (19/32) | NS (0.84)2 |
Head in a “sniffing” position | 100 (50/50) | 94 (47/50) | 94 (47/50) | 94.4 (17/18) | 93.7 (30/32) | NS (0.71)1 |
Clearing the airway | 96 (48/50) | 96 (48/50) | 62.5 (30/48) | 55.6 (10/18) | 66.7 (20/30) | NS (0.59)2 |
Stimulation | 64 (32/50) | 30 (15/50) | 93.34 (14/15) | 80 (4/5) | 100 (10/10) | NS (0.33)1 |
Placing a preductal pulse-oximeter probe | 82 (41/50) | 90.2 (37/41) | 63.4 (26/41) | 76.9 (10/13) | 57.1 (16/28) | NS (1.49)1 |
Administration of oxygen | 68 (34/50) | 68 (34/50) | 94.1 (32/34) | 100 (10/10) | 91.3 (21/23) | NS (0.48)1 |
CPAP | 60 | 60 | 100 | 100 | 100 | – |
Administration of PPV | 60 (30/50) | 96.7 (29/30) | 79.3 (23/29) | 60 (6/10) | 85 (17/20) | NS (0.14)1 |
Intubation | 32 (16/50) | 87.5 (14/16) | 0 (0/16) | 0 (0/5) | 0 (0/11) | – |
CC | 4 (2/50) | 2 (1/50) | 0 | 0 | 0 | – |
Epinephrine administration | ? | 4 (2/50) | 0 | 0 | 0 | – |
Surfactant administration | 24 (12/50) | 20 (10/50) | 1004 (10/10) 83.3 (10/12)5 | 75 (3/4) | 87.5 (7/8) | NS (0.58)1 |